In recent years, with the continuous increase in the incidence of cerebral palsy, people's attention to this condition has been growing. It is explained that cerebral palsy refers to a non-progressive brain injury syndrome caused by various reasons before birth, during birth, or in the early infancy period. Its main manifestations include central motor disorders and posture abnormalities, often accompanied by intellectual disabilities, seizures, behavioral abnormalities, sensory impairments, and other anomalies. It is one of the main causes of childhood disabilities. It can be said that cerebral palsy not only inflicts significant physical and mental harm on affected children but also imposes a heavy burden on their families.
Nuolai Biomedical Technology Co., Ltd. (referred to as Nuolai Medical), has been adhering to the service concept of "preventing major diseases and promoting health" since its establishment. It advocates the service tenet of "priority to quality, innovation as the source, integrity as the foundation, and reputation as the focus." Specializing in research and development in the health industry, Nuolai Medicine has made significant breakthroughs, especially in the treatment of functionally neurological diseases that are difficult to cure, including childhood cerebral palsy.
To better treat childhood cerebral palsy and similar conditions, Nuolai Medical collaborates with Professor Tian Zengmin's team, a renowned expert in functional neurosurgery in China, to jointly establish the Nuolai Medical Functional Neurosurgery Center, integrating the development, production, sales of stereotactic robotic devices, and the treatment of functional neurological disorders.
The frameless brain stereotactic surgery, abbreviated as robotic brain stereotactic surgery, is a brain surgery conducted by Professor Tian Zengmin and his team using the RuiMi neurosurgical robot. Professor Tian Zengmin's team, based on traditional stereotactic surgery, replaces the traditional metal frame structure with a robotic arm to achieve precise positioning, avoiding the pain caused to patients by installing a head frame, and making the operation simpler and more feasible. Currently, this technology has successfully completed more than 20,000 surgeries, showing remarkable improvements in nearly a hundred types of neurological disorders, including cerebral palsy, epilepsy, cerebral hemorrhage, Parkinson's disease, etc.
The Reme neurosurgical robot used in surgery integrates dozens of patented inventions, providing advantages such as minimally invasive surgery, precise positioning, and high surgical efficiency. During the operation, it assists the doctor in clear and intuitive observation of the lesion, surrounding tissues, and vascular distribution, planning the best surgical puncture pathway. The entire surgery takes only 30 minutes, with a positioning accuracy of 0.5 millimeters, a minimal incision of 2-3 millimeters, and patients can be discharged after 2-3 days of post-operative observation. This brings new hope to patients with brain and nervous system injuries worldwide.
Furthermore, the Nuolai Medical Functional Neurosurgery Center has invested heavily in building an internationally first-class hundred-level purified operating room and introduced internationally renowned equipment brands such as Stryker and GE. The superior medical environment and advanced supporting facilities provide higher assurance for the perfect implementation of surgeries.
In the future, Nuolai Medical will continue to uphold the vision of promoting the development of a new era in medicine and enhancing the guarantee of human health, bringing good news to numerous patients suffering from functional neurological diseases, including cerebral palsy, and their families.